Olstein Capital Management’s CVS Health CVS Stock Holding History

Olstein Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$3.59M	–	20
2026 Q1	$3.59M	Sell	50,000 -6,000	-11%	-$462K	0.78%	67
2025 Q4	$4.44M	Sell	56,000 -13,000	-19%	-$1.02M	0.91%	59
2025 Q3	$5.2M	Sell	69,000 -8,000	-10%	-$548K	0.98%	53
2025 Q2	$5.31M	Sell	77,000 -33,000	-30%	-$2.16M	1%	56
2025 Q1	$7.45M	Sell	110,000 -13,000	-11%	-$778K	1.37%	30
2024 Q4	$5.52M	Sell	123,000 -42,000	-25%	-$2.36M	0.97%	57
2024 Q3	$10.4M	Buy	165,000 +10,000	+6%	+$583K	1.77%	6
2024 Q2	$9.15M	Buy	155,000 +26,000	+20%	+$1.63M	1.63%	9
2024 Q1	$10.3M	Sell	129,000 -13,000	-9%	-$993K	1.68%	8
2023 Q4	$11.2M	Sell	142,000 -13,000	-8%	-$925K	1.89%	6
2023 Q3	$10.8M	Buy	155,000 +17,000	+12%	+$1.2M	1.86%	5
2023 Q2	$9.54M	Buy	138,000 +20,000	+17%	+$1.42M	1.54%	13
2023 Q1	$8.77M	Buy	118,000 +40,000	+51%	+$3.35M	1.37%	22
2022 Q4	$7.27M	Buy	78,000 +2,000	+3%	+$193K	1.14%	43
2022 Q3	$7.25M	Hold	76,000	–	–	1.21%	37
2022 Q2	$7.04M	Sell	76,000 -23,000	-23%	-$2.24M	1.06%	41
2022 Q1	$10M	Sell	99,000 -27,000	-21%	-$2.84M	1.26%	29
2021 Q4	$13M	Sell	126,000 -51,000	-29%	-$4.71M	1.55%	10
2021 Q3	$15M	Sell	177,000 -3,000	-2%	-$251K	1.84%	4
2021 Q2	$15M	Hold	180,000	–	–	1.89%	6
2021 Q1	$13.5M	Buy	180,000 +11,000	+7%	+$801K	1.89%	6
2020 Q4	$11.5M	Buy	169,000 +2,000	+1%	+$130K	1.84%	9
2020 Q3	$9.75M	Buy	167,000 +23,000	+16%	+$1.43M	1.77%	9
2020 Q2	$9.36M	Hold	144,000	–	–	1.75%	9
2020 Q1	$8.54M	Buy	144,000 +19,500	+16%	+$1.3M	1.87%	4
2019 Q4	$9.25M	Sell	124,500 -61,800	-33%	-$4.34M	1.43%	13
2019 Q3	$11.8M	Buy	186,300 +3,300	+2%	+$196K	1.84%	2
2019 Q2	$9.97M	Buy	183,000 +6,000	+3%	+$323K	1.62%	6
2019 Q1	$9.55M	Buy	177,000 +50,000	+39%	+$3.09M	1.57%	8
2018 Q4	$8.32M	Sell	127,000 -1,000	-0.8%	-$74.6K	1.36%	18
2018 Q3	$10.1M	Sell	128,000 -36,000	-22%	-$2.57M	1.35%	14
2018 Q2	$10.6M	Sell	164,000 -21,000	-11%	-$1.38M	1.4%	17
2018 Q1	$11.5M	Buy	185,000 +48,500	+36%	+$3.48M	1.46%	13
2017 Q4	$9.9M	Buy	136,500 +17,500	+15%	+$1.27M	1.26%	24
2017 Q3	$9.68M	Sell	119,000 -5,925	-5%	-$469K	1.25%	23
2017 Q2	$10.1M	Buy	124,925 +3,000	+2%	+$237K	1.28%	20
2017 Q1	$9.57M	Sell	121,925 -18,075	-13%	-$1.44M	1.23%	28
2016 Q4	$11M	Buy	140,000 +32,000	+30%	+$2.59M	1.42%	17
2016 Q3	$9.61M	Buy	108,000 +17,000	+19%	+$1.6M	1.27%	25
2016 Q2	$8.71M	Buy	91,000 +27,000	+42%	+$2.69M	1.18%	31
2016 Q1	$6.64M	Hold	64,000	–	–	0.89%	54
2015 Q4	$6.26M	Buy	64,000 +19,000	+42%	+$1.86M	0.81%	57
2015 Q3	$4.34M	Sell	45,000 -12,000	-21%	-$1.26M	0.54%	83
2015 Q2	$5.98M	Hold	57,000	–	–	0.62%	80
2015 Q1	$5.88M	Sell	57,000 -18,000	-24%	-$1.82M	0.64%	83
2014 Q4	$7.22M	Sell	75,000 -17,000	-18%	-$1.5M	0.88%	53
2014 Q3	$7.32M	Hold	92,000	–	–	0.95%	46
2014 Q2	$6.93M	Hold	92,000	–	–	0.94%	48
2014 Q1	$6.89M	Buy	+92,000	New	+$6.5M	0.94%	49

Other funds holding CVS

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Olstein Capital Management's CVS Position: Q2 2026 in Review

Olstein Capital Management sold out of CVS Health (CVS) in Q2 2026, closing a stake of 50,000 shares — an estimated $3.59M sold.

Olstein Capital Management first reported a position in CVS in Q1 2014 and held it in 49 quarters. The position peaked at $15M in Q3 2021. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Olstein Capital Management reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
Olstein Capital Management sold 50,000 CVS Health shares in Q2 2026, an estimated $3.59M.
Olstein Capital Management first reported a position in CVS Health in Q1 2014 and held it in 49 quarters.
Olstein Capital Management's CVS Health position peaked at $15M in Q3 2021.
937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Olstein Capital Management's 13F filing for Q2 2026.